Celiac screening in type 1 diabetes, Down syndrome and Turner syndrome: what the guidelines say

Short answer

The guidelines we read name a tTG-IgA blood test, with total IgA, as the first test in all three groups1, 2, 3, but they differ on who is tested without symptoms and how often:

  1. Type 1 diabetes, children and adolescents: the American Diabetes Association’s 2026 Standards say to screen soon after diagnosis and repeat within 2 years and again after 51, 4.
  2. Type 1 diabetes, adults: the same Standards tie screening to gastrointestinal symptoms, signs, laboratory manifestations or clinical suspicion5.
  3. Turner syndrome: the 2023 international guideline recommends screening people without symptoms from age 2, then every 2 to 5 years2.
  4. Down syndrome: the American Academy of Pediatrics (2022) says there is no evidence that routine screening of people without symptoms would be beneficial6, while a 2026 systematic review found other guidelines that support universal screening7.

Published by Gluten Verdict · updated · 13 sources, each linked below

Reviewed by Mark Peter, Registered dietitian (RD), on

Kitchen fridge door with a reminder card, a meter case and a child's backpack

Key points

  • Guidelines do not give one rule for all three groups: the type 1 diabetes advice differs for children and adults4, 5, and for Down syndrome the guidelines split between universal and symptom-based testing7.
  • The Turner syndrome guideline is the most specific of the three: tTG-IgA with total IgA from age 2, then every 2 to 5 years2.
  • Antibody tests need gluten in the diet; NIDDK says doctors do not recommend starting a gluten-free diet before diagnostic testing8.
  • A positive antibody result is not the diagnosis on its own: the guidelines we read refer to a specialist or recommend a biopsy to confirm9, 10, 11, apart from ESPGHAN’s no-biopsy route for children12.
  • A gene test (HLA-DQ2 and DQ8) is not a screening test for these groups in the type 1 diabetes and Turner syndrome guidelines13, 14.

Which of these groups have higher rates, and whose numbers are they?

NIDDK says celiac disease is more common in people with certain chromosomal disorders, such as Down syndrome, Turner syndrome and Williams syndrome15. It also lists type 1 diabetes among the immune-related disorders some people have alongside celiac disease16.

Celiac disease rates as each source states them
GroupFigureWhose figure
Type 1 diabetes1.6–16.4% of people with type 1 diabetes, against 0.3–1% in the general population17American Diabetes Association, Standards of Care 2026
Type 1 diabetes, children and adolescents1%–16.4%18ISPAD, 2022 chapter
Turner syndromeAbout 1 in 22, from a meta-analysis the guideline cites19; up to 7.5% with positive antibodies in some karyotypes202023 international Turner syndrome guideline
Down syndrome1%–5%21American Academy of Pediatrics, 2022
Down syndrome1.6%–18.6%, against about 1% in the general population222026 systematic review

The ranges are wide. ISPAD cites one international comparison of 53,000 children and adolescents with type 1 diabetes that found biopsy-proven celiac disease from 1.9% in the U.S. to 7.7% in Australia23.

What is the first test the guidelines name?

The guidelines that name a first test start with an antibody blood test for tissue transglutaminase IgA (tTG-IgA, also written TGA-IgA), read alongside total IgA. ESPGHAN’s 2020 guideline recommends testing total IgA and TGA-IgA as initial screening in children with suspected celiac disease24. The ADA children’s recommendation names IgA tTG antibodies with documentation of acceptable serum IgA levels1. The Turner syndrome guideline names tTG-IgA with total IgA2, and the AAP’s Down syndrome report names tTG-IgA with a simultaneous quantitative IgA3.

The reason for the second number is IgA deficiency. The AAP says a deficiency renders the tTG-IgA unreliable25, and the Celiac Disease Foundation says it can cause a false negative result26. ISPAD says screening for IgA deficiency should be performed at the time of celiac disease screening27. Where IgA is low, the ADA recommendation switches to IgG tTG and deamidated gliadin antibodies1.

What follows a positive result

ESPGHAN says patients with positive results should be referred to a paediatric gastroenterologist or specialist9. NIDDK says doctors most often use blood tests and biopsies of the small intestine to diagnose or rule out celiac disease28. The Turner syndrome guideline recommends a biopsy to confirm10, and the ADA recommends one when the diagnosis is in question, especially in asymptomatic children and adolescents11.

ESPGHAN also describes a route without a biopsy for children: when tTG-IgA is at least 10 times the upper limit of normal, the family agrees, and a second blood sample is positive for endomysial antibodies12. See our guide to the celiac blood test for how the antibody tests are read.

Type 1 diabetes: children and adults get different advice

Children and adolescents

The ADA’s 2026 Standards recommend screening soon after the diabetes diagnosis1, repeating within 2 years, and again after 5 years, with more frequent screening to consider for children who have symptoms or a first-degree relative with celiac disease4. The ADA’s reason is that most cases of celiac disease are diagnosed within the first 5 years after the type 1 diabetes diagnosis29.

ISPAD’s 2022 chapter recommends screening during the initial year of diabetes diagnosis and at 2–5 year intervals30, with more frequent assessment when symptomatic celiac disease is possible or a child has a first-degree relative with it31. It also allows that screening in asymptomatic children may be deferred after the period of initial diagnosis, because managing new-onset diabetes and celiac disease together may be overwhelming for children and families32.

Type 1 diabetes: what each guideline says about timing
GuidelineWho it coversWhat it says
American Diabetes Association, 2026Children and adolescentsScreen soon after diagnosis; repeat within 2 years, then after 5 years1, 4
ISPAD, 2022Children and adolescentsScreening recommended during the initial year and at 2–5 year intervals30
American College of Gastroenterology, 2023ChildrenYearly or every-other-year serology “has been suggested”33
American Diabetes Association, 2026AdultsScreen when there are gastrointestinal symptoms, signs, laboratory manifestations or clinical suspicion5
American College of Gastroenterology, 2023Patients with type 1 diabetesTest if there are any suggestive symptoms or signs34

Adults

For adults the ADA ties screening to symptoms, signs, laboratory findings or clinical suspicion5, and lists symptoms such as diarrhea, malabsorption and abdominal pain and signs such as osteoporosis, vitamin deficiencies and iron deficiency anemia35. The ACG likewise says patients with type 1 diabetes should be tested if there are any suggestive symptoms or signs34.

A 2024 review in Gastroenterology takes a wider view: it lists type 1 diabetes among the conditions with a high celiac prevalence for which it recommends screening36. NIDDK’s diagnosis page (last reviewed October 2020) says doctors in the United States do not routinely screen people for celiac disease, but that people with type 1 diabetes should talk with their doctor about their chances of getting the disease to see if they should be tested37. Our guide to type 1 diabetes and celiac disease goes further into the overlap.

Down syndrome: the guidelines split

The American Academy of Pediatrics’ 2022 report asks pediatricians to review children on a gluten-containing diet for symptoms potentially related to celiac disease at each health supervision visit, because children with Down syndrome are at increased risk38. For those with symptoms it asks for a tTG-IgA and a simultaneous quantitative IgA3. On screening without symptoms it is direct: there is no evidence that routine screening of asymptomatic individuals would be beneficial6.

Other bodies read the same condition differently. A 2026 systematic review in the Journal of Pediatric Gastroenterology and Nutrition compared seven clinical practice guidelines and two clinical practice reports39. It found recommendations “varied widely”: it gives BSPGHAN, DSMIG, ESsCD, ESPGHAN and NASPGHAN as examples of universal screening and the AAP, AGA, ACG and NICE as examples of symptom-based testing7. The review describes the split as a philosophical divide between maximizing early detection and minimizing overdiagnosis and its consequent unnecessary treatments40.

ESPGHAN’s own 2020 guideline recommends considering testing in children and adolescents with the symptoms, signs and conditions in its Table 241, and that table names Down syndrome42. The Celiac Disease Foundation also lists Down syndrome among the conditions for which it advises screening43.

Turner syndrome: the 2023 international guideline

The guideline from the 2023 Aarhus International Turner Syndrome Meeting recommends screening for celiac disease with tTG-IgA and total IgA in individuals without symptoms, starting at age 2 and repeating every 2 to 5 years2. It separately recommends screening at any age when there are gastrointestinal symptoms, poor growth, weight loss, osteoporosis, skin changes, anemia or other symptoms44.

The guideline reports that a meta-analysis found approximately 1 in 22 people with Turner syndrome have celiac disease19, and that antibody positivity of up to 7.5% is reported in some karyotypes20. The guideline says intestinal biopsy is recommended to confirm the diagnosis10.

Why “no symptoms” does not settle it

The guidelines differ on people without symptoms. ISPAD says celiac disease is frequently asymptomatic in children and young adults with type 1 diabetes, which makes finding cases by symptoms challenging45. The Down syndrome review reports that in one Finnish cohort, 48.2% of screen-detected children were asymptomatic at diagnosis46.

Two cautions about positive results appear in the sources. ISPAD notes that a positive tTG-IgA at screening may be transient47, and the Celiac Disease Foundation says there is a slight risk of a false positive, especially for people with associated autoimmune disorders such as type 1 diabetes48.

ESPGHAN’s 2020 guideline gives a conditional recommendation that celiac disease can be diagnosed without duodenal biopsies in asymptomatic children, using the same criteria as in patients with symptoms, and asks that the decision be shared with the parents and, if appropriate, the child49.

Antibody tests need gluten in the diet

The Celiac Disease Foundation says a person must be on a gluten-containing diet for antibody testing to be accurate50. NIDDK says doctors do not recommend starting a gluten-free diet before diagnostic testing, because it can affect test results8, and the AAP’s Down syndrome report says not to start one before the diagnosis is confirmed51.

If a family has already stopped gluten, our guide to the gluten challenge explains what the sources say about going back before a test.

Other groups on the lists, and where a gene test fits

Williams syndrome and IgA deficiency appear next to Down syndrome and Turner syndrome on the lists we read: NIDDK names Williams syndrome among the chromosomal disorders15, ESPGHAN’s Table 2 names Williams-Beuren syndrome and IgA deficiency42, and the Celiac Disease Foundation lists Williams syndrome and selective IgA deficiency43. The 2024 Gastroenterology review’s list also includes Hashimoto’s thyroiditis, Graves’ disease, Sjögren’s syndrome and dermatitis herpetiformis, among others, and says serology should be the initial step36, 52.

Where HLA-DQ2 and DQ8 testing fits

NIDDK says that people without the DQ2 and DQ8 gene variants are very unlikely to have celiac disease53, and that having them does not mean a person has it, since most people with these variants do not develop celiac disease54.

  • Type 1 diabetes: ISPAD says HLA-DQ2 and DQ8 measurement is rarely helpful to exclude celiac disease in people with type 1 diabetes and is not recommended as a screening test13. The ADA notes that about 95% of people with type 1 diabetes carry HLA-DQ2 and/or DQ8, so genetic testing may not be needed55.
  • Turner syndrome: the guideline says routine HLA testing is not currently recommended, although it may help if the diagnosis is uncertain14.
  • Down syndrome: ESPGHAN notes that HLA typing in at-risk groups may not be cost-effective for type 1 diabetes because of the high share of HLA-positive people, but may be in other groups, for example in Down syndrome56.

More on the genes is in our guides to celiac genetic testing and to gene carriers who never develop celiac disease.

Questions people ask

Do all guidelines advise testing a child with Down syndrome who has no symptoms?

No. A 2026 systematic review found recommendations ranging from universal screening to symptom-based testing7, and the AAP says there is no evidence that routine screening of people without symptoms would be beneficial6.

At what age does the Turner syndrome guideline start celiac screening?

The 2023 international guideline recommends starting at age 2 in individuals without symptoms, then every 2 to 5 years2.

How often do guidelines repeat celiac screening in type 1 diabetes?

For children and adolescents the ADA says to repeat within 2 years of diagnosis and again after 5 years4, and ISPAD recommends screening in the initial year and at 2–5 year intervals30. The ACG says yearly or every-other-year serology has been suggested for children33.

Does a gene test replace the antibody test?

No. NIDDK says having DQ2 or DQ8 alone does not mean a person has celiac disease54, and ISPAD does not recommend HLA measurement as a screening test in type 1 diabetes13.

Is there a screening rule for adults with type 1 diabetes?

The ADA’s 2026 Standards recommend screening adults with type 1 diabetes in the presence of gastrointestinal symptoms, signs, laboratory manifestations or clinical suspicion5.

More in Celiac genetics and family risk

Sources